Oncolytics Biotech Inc. (NASDAQ: ONCY) has experienced a rise in its stock price by 20.11 compared to its previous closing price of 1.79. However, the company has seen a gain of 37.82% in its stock price over the last five trading days.
Is It Worth Investing in Oncolytics Biotech Inc. (NASDAQ: ONCY) Right Now?
The 36-month beta value for ONCY is also noteworthy at 2.04.
25-cent Stock Takes $11T Commodities Sector Digital
One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.
All the details are in the FREE online report you can get here.
Sponsored
The public float for ONCY is 58.26M, and at present, short sellers hold a 0.12% of that float. The average trading volume of ONCY on May 25, 2023 was 179.84K shares.
ONCY’s Market Performance
The stock of Oncolytics Biotech Inc. (ONCY) has seen a 37.82% increase in the past week, with a 90.27% rise in the past month, and a 32.72% gain in the past quarter. The volatility ratio for the week is 11.67%, and the volatility levels for the past 30 days are at 9.95% for ONCY. The simple moving average for the past 20 days is 33.92% for ONCY’s stock, with a 45.61% simple moving average for the past 200 days.
ONCY Trading at 57.61% from the 50-Day Moving Average
After a stumble in the market that brought ONCY to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -5.70% of loss for the given period.
Volatility was left at 9.95%, however, over the last 30 days, the volatility rate increased by 11.67%, as shares surge +69.29% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +65.38% upper at present.
During the last 5 trading sessions, ONCY rose by +37.82%, which changed the moving average for the period of 200-days by +66.67% in comparison to the 20-day moving average, which settled at $1.6500. In addition, Oncolytics Biotech Inc. saw 31.90% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for ONCY
Equity return is now at value -87.90, with -64.50 for asset returns.
Conclusion
In summary, Oncolytics Biotech Inc. (ONCY) has had a better performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
